Simplex Trading’s Oric Pharmaceuticals ORIC Stock Holding History

Simplex Trading’s Portfolio ORIC Stock Details ORIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.33K	Hold	400	–	–	﹤0.01%	8260
2026 Q1	$5.07K	Buy	+400	New	+$4.54K	﹤0.01%	7887
2025 Q2	–	Sell	-1,000	Closed	-$5K	–	9450
2025 Q1	$5K	Buy	+1,000	New	+$8.74K	﹤0.01%	7572
2024 Q2	–	Sell	-800	Closed	-$11K	–	9540
2024 Q1	$11K	Buy	+800	New	+$9.5K	﹤0.01%	7556
2023 Q3	–	Sell	-11,800	Closed	-$91K	–	9503
2023 Q2	$91K	Buy	+11,800	New	+$67K	﹤0.01%	5191
2023 Q1	–	Sell	-200	Closed	-$1K	–	9829
2022 Q4	$1K	Sell	200 -47,400	-100%	-$160K	﹤0.01%	8880
2022 Q3	$152K	Hold	47,600	–	–	﹤0.01%	4972
2022 Q2	$213K	Buy	+47,600	New	+$190K	﹤0.01%	4527

Other funds holding ORIC

Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

SOCM

SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return

VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Simplex Trading's ORIC Position: Q2 2026 in Review

Simplex Trading increased its Oric Pharmaceuticals (ORIC) stake by 427% in Q2 2026, buying an estimated $52.2K and bringing the position to 7,106 shares worth $77K. The position accounts for ﹤0.01% of the portfolio, ranked #5859.

Simplex Trading first reported a position in ORIC in Q2 2021 and has held it in 13 quarters since. The position peaked at $225K in Q2 2023. 181 funds tracked by Wall St. Rank hold ORIC as of Q2 2026.

Simplex Trading held 7,106 shares of Oric Pharmaceuticals worth $77K as of Q2 2026.
Simplex Trading bought 5,758 Oric Pharmaceuticals shares in Q2 2026, an estimated $52.2K.
Oric Pharmaceuticals made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #5859 holding.
Simplex Trading first reported a position in Oric Pharmaceuticals in Q2 2021 and has held it in 13 quarters since.
Simplex Trading's Oric Pharmaceuticals position peaked at $225K in Q2 2023.
181 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.